Establishment Labs price target lowered to $80 from $110 at Mizuho

Mizuho analyst Anthony Petrone lowered the firm’s price target on Establishment Labs to $80 from $110 and keeps a Buy rating on the shares. The analyst lower targets on several medical technology names ahead of the Q3 earnings season to reflect inputs from hospital/physician surveys and key opinion leader channel checks. The target drops account for the sharp intra-quarter contraction driven in part by GLP-1 risk concerns, the analyst tells investors in a research note.